Confronti finanziari Eurofins Scientific SE
Azioni
ERF
FR0014000MR3
Prestatari di assistenza sanitaria
Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
47,11 EUR | +1,07% | +0,68% | -20,13% |
28/11 | EUROFINS SCIENTIFIC : Il NAV è stato ridotto del -6,0%. | |
23/10 | EUROFINS SCIENTIFIC : la biofarmaceutica pesa sulla crescita di Eurofins nel terzo trimestre |
Aggiungi a un elenco 0 selezionato | Fatturato ($) (Y-1) | Margine netto (Y-1) | Margine Operativo (Y-1) | ROE (Y-1) | ROA (Y-1) | Leva (indebitamento/EBITDA) (Y-1) | |
---|---|---|---|---|---|---|---|
6,88 Mrd | +4.76% | +12.92% | +6.29% | +2.96% | 1.98x | ||
64,97 Mrd | +8.07% | +14.85% | +364.75% | +9.46% | 3.04x | ||
358 Mrd | +2.33% | +4.90% | +15.24% | +4.72% | 2.51x | ||
2,53 Mrd | +21.52% | +22.04% | +33.10% | +14.42% | 1.06x | ||
1,08 Mrd | -40.16% | -41.22% | -59.11% | -30.66% | 1.25x | ||
23,56 Mrd | -2.66% | +10.14% | +7.90% | +2.47% | 3.88x | ||
12,16 Mrd | +3.44% | +14.10% | +13.22% | +6.44% | 2.18x | ||
9,25 Mrd | +9.23% | +15.75% | +14.00% | +6.36% | 2.34x | ||
20,56 Mrd | +2.57% | +7.04% | +4.99% | +2.17% | 3.45x | ||
20,55 Mrd | +2.97% | +13.00% | +44.44% | +2.20% | 3.89x | ||
12,14 Mrd | +5.70% | +14.28% | +89.23% | +4.67% | 3.2x | ||
14,28 Mrd | +5.03% | +8.23% | +11.89% | +5.23% | 2.75x | ||
638 Mln | +19.56% | +23.07% | +13.37% | +9.57% | 0.13x | ||
7,67 Mrd | +4.50% | +9.66% | +9.52% | +2.37% | 0.87x | ||
4,46 Mrd | +5.88% | - | - | - | - | ||
2,26 Mrd | +12.03% | +17.39% | +32.36% | - | - | ||
746 Mln | +27.61% | +32.71% | +31.80% | +26.20% | -1.13x | ||
4,3 Mrd | +6.21% | +7.31% | +19.03% | +8.44% | 1.69x | ||
2,93 Mrd | -0.74% | +18.62% | +11.45% | +6.19% | 1.88x | ||
Media | 29,94 Mrd | +5,15% | +11,38% | +36,86% | +4,89% | 2,06x | |
Media ponderata per Capi. | 86,42 Mrd | +4,08% | +9,45% | +92,60% | +4,56% | 2,40x |
- Borsa valori
- Azioni
- Azione ERF
- Settore Eurofins Scientific SE
- Confronti finanziari
MarketScreener is also available in this country: United States.
Switch edition